Aclaris Therapeutics Stock Price History

ACRS Stock  USD 1.61  0.02  1.26%   
If you're considering investing in Aclaris Stock, it is important to understand the factors that can impact its price. As of today, the current price of Aclaris Therapeutics stands at 1.61, as last reported on the 19th of July, with the highest price reaching 1.63 and the lowest price hitting 1.58 during the day. Aclaris Therapeutics appears to be risky, given 3 months investment horizon. Aclaris Therapeutics secures Sharpe Ratio (or Efficiency) of 0.16, which signifies that the company had a 0.16 % return per unit of risk over the last 3 months. By analyzing Aclaris Therapeutics' technical indicators, you can evaluate if the expected return of 0.66% is justified by implied risk. Please makes use of Aclaris Therapeutics' Mean Deviation of 3.32, downside deviation of 3.61, and Risk Adjusted Performance of 0.1541 to double-check if our risk estimates are consistent with your expectations.
Aclaris Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.1567

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsACRS
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 4.2
  actual daily
37
63% of assets are more volatile

Expected Return

 0.66
  actual daily
13
87% of assets have higher returns

Risk-Adjusted Return

 0.16
  actual daily
12
88% of assets perform better
Based on monthly moving average Aclaris Therapeutics is performing at about 12% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Aclaris Therapeutics by adding it to a well-diversified portfolio.

Aclaris Therapeutics Stock Price History Chart

There are several ways to analyze Aclaris Stock price data. The simplest method is using a basic Aclaris candlestick price chart, which shows Aclaris Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceJune 25, 20251.63
Lowest PriceMay 14, 20251.18

Aclaris Therapeutics July 19, 2025 Stock Price Synopsis

Various analyses of Aclaris Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Aclaris Stock. It can be used to describe the percentage change in the price of Aclaris Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Aclaris Stock.
Aclaris Therapeutics Price Daily Balance Of Power 0.40 
Aclaris Therapeutics Price Rate Of Daily Change 1.01 
Aclaris Therapeutics Price Action Indicator 0.02 

Aclaris Therapeutics July 19, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Aclaris Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Aclaris Therapeutics intraday prices and daily technical indicators to check the level of noise trading in Aclaris Stock and then apply it to test your longer-term investment strategies against Aclaris.

Aclaris Stock Price History Data

The price series of Aclaris Therapeutics for the period between Sun, Apr 20, 2025 and Sat, Jul 19, 2025 has a statistical range of 0.53 with a coefficient of variation of 9.4. The prices are distributed with arithmetic mean of 1.41. The median price for the last 90 days is 1.44.
OpenHighLowCloseVolume
07/19/2025
 1.61  1.63  1.58  1.61 
07/18/2025
 1.61  1.63  1.58  1.61  650,344 
07/17/2025
 1.57  1.63  1.56  1.59  550,035 
07/16/2025
 1.54  1.58  1.51  1.58  507,877 
07/15/2025
 1.57  1.60  1.52  1.52  556,503 
07/14/2025
 1.57  1.68  1.56  1.58  906,112 
07/11/2025
 1.59  1.61  1.54  1.57  585,151 
07/10/2025
 1.61  1.63  1.54  1.59  1,270,971 
07/09/2025
 1.44  1.57  1.44  1.54  626,132 
07/08/2025
 1.46  1.50  1.45  1.45  577,109 
07/07/2025
 1.48  1.50  1.44  1.46  568,357 
07/03/2025
 1.46  1.49  1.44  1.44  402,410 
07/02/2025
 1.43  1.52  1.39  1.45  733,124 
07/01/2025
 1.44  1.47  1.38  1.41  715,066 
06/30/2025
 1.45  1.47  1.39  1.42  980,906 
06/27/2025
 1.63  1.63  1.42  1.47  11,547,310 
06/26/2025
 1.65  1.66  1.55  1.56  993,559 
06/25/2025
 1.56  1.63  1.54  1.63  953,669 
06/24/2025
 1.42  1.52  1.39  1.52  681,449 
06/23/2025
 1.46  1.46  1.34  1.39  1,474,229 
06/20/2025
 1.42  1.45  1.40  1.45  887,058 
06/18/2025
 1.42  1.46  1.37  1.42  738,311 
06/17/2025
 1.43  1.49  1.40  1.40  522,832 
06/16/2025
 1.48  1.54  1.44  1.44  609,224 
06/13/2025
 1.50  1.55  1.47  1.47  471,062 
06/12/2025
 1.57  1.57  1.52  1.53  420,503 
06/11/2025
 1.53  1.59  1.48  1.57  846,581 
06/10/2025
 1.50  1.55  1.45  1.51  299,379 
06/09/2025
 1.55  1.55  1.47  1.49  786,932 
06/06/2025
 1.55  1.65  1.53  1.53  737,323 
06/05/2025
 1.63  1.63  1.54  1.56  637,235 
06/04/2025
 1.48  1.65  1.47  1.61  1,688,681 
06/03/2025
 1.45  1.51  1.42  1.47  427,751 
06/02/2025
 1.47  1.53  1.42  1.44  646,039 
05/30/2025
 1.45  1.48  1.39  1.46  751,142 
05/29/2025
 1.44  1.46  1.38  1.46  792,288 
05/28/2025
 1.36  1.56  1.35  1.41  2,806,981 
05/27/2025
 1.32  1.34  1.27  1.27  623,976 
05/23/2025
 1.25  1.29  1.22  1.26  404,728 
05/22/2025
 1.28  1.31  1.25  1.26  462,350 
05/21/2025
 1.35  1.38  1.27  1.29  641,660 
05/20/2025
 1.30  1.38  1.28  1.35  489,036 
05/19/2025
 1.29  1.34  1.27  1.30  531,120 
05/16/2025
 1.20  1.32  1.18  1.31  491,151 
05/15/2025
 1.19  1.24  1.16  1.22  536,285 
05/14/2025
 1.22  1.25  1.16  1.18  478,418 
05/13/2025
 1.26  1.27  1.22  1.22  413,298 
05/12/2025
 1.30  1.35  1.24  1.25  430,838 
05/09/2025
 1.26  1.38  1.26  1.26  524,173 
05/08/2025
 1.28  1.33  1.25  1.31  1,061,866 
05/07/2025
 1.29  1.30  1.20  1.25  583,318 
05/06/2025
 1.27  1.28  1.22  1.28  1,069,936 
05/05/2025
 1.44  1.45  1.28  1.28  383,567 
05/02/2025
 1.40  1.46  1.37  1.44  668,869 
05/01/2025
 1.38  1.40  1.33  1.38  280,667 
04/30/2025
 1.30  1.40  1.27  1.38  440,602 
04/29/2025
 1.49  1.49  1.30  1.33  431,641 
04/28/2025
 1.35  1.39  1.34  1.36  712,545 
04/25/2025
 1.27  1.36  1.26  1.34  508,812 
04/24/2025
 1.19  1.33  1.19  1.27  1,008,586 
04/23/2025
 1.17  1.20  1.12  1.19  1,192,666 

About Aclaris Therapeutics Stock history

Aclaris Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Aclaris is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Aclaris Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Aclaris Therapeutics stock prices may prove useful in developing a viable investing in Aclaris Therapeutics
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. The company was incorporated in 2012 and is headquartered in Wayne, Pennsylvania. Aclaris Therapts operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 72 people.

Aclaris Therapeutics Stock Technical Analysis

Aclaris Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Aclaris Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Aclaris Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Portfolio Dashboard Now

   

Portfolio Dashboard

Portfolio dashboard that provides centralized access to all your investments
All  Next Launch Module

Aclaris Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Aclaris Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Aclaris Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Aclaris to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for Aclaris Stock Analysis

When running Aclaris Therapeutics' price analysis, check to measure Aclaris Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aclaris Therapeutics is operating at the current time. Most of Aclaris Therapeutics' value examination focuses on studying past and present price action to predict the probability of Aclaris Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aclaris Therapeutics' price. Additionally, you may evaluate how the addition of Aclaris Therapeutics to your portfolios can decrease your overall portfolio volatility.